Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up 0.59% Nasdaq Up 0.66%
Streaming
Ticker Tape: On

More On PBMD

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Prima Biomed Ltd. (PBMD)

-NasdaqGM
1.03 Down 0.02(1.90%) 9:30AM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:1.05
Open:N/A
Bid:1.03 x 3500
Ask:1.17 x 2000
1y Target Est:N/A
Beta:3.232
Next Earnings Date:N/A
Day's Range:1.03 - 1.03
52wk Range:0.82 - 3.43
Volume:2,500
Avg Vol (3m):224,076
Market Cap:42.18M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PBMD

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Prima BioMed Ltd., a biotechnology company, researches, develops, and commercializes licensed medical biotechnology products in Australia. Its lead product includes CVac, a cancer vaccine for patients in remission, which has completed two human cl... View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback